Consumers Urge Wider Recall In Ranbaxy Glass Shards Action

Law360, New York (January 28, 2013, 1:19 PM EST) -- Consumers who purchased Ranbaxy Laboratories Ltd.'s generic version of cholesterol drug Lipitor asked a New Jersey federal judge Friday to order a complete recall of pills tainted with glass shards, alleging in their proposed class action that reports of significant patient harm are emerging.

The motion for a preliminary injunction, filed two months after Ranbaxy announced it was conducting a limited recall of atorvastatin tablets that might contain tiny bits of glass, contends that patients experienced pain after using the medicine despite assurances from the Indian...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

FENWICK v. RANBAXY PHARMACEUTICALS, INC. et al


Case Number

3:12-cv-07354

Court

New Jersey

Nature of Suit

Other Statutory Actions

Judge

Peter G. Sheridan

Date Filed

November 29, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.